IP Library Granted Patent US 9,895,328
Granted Patent B2
US 9,895,328 · App. 14/912,044 · Granted Feb 20, 2018

Calcium formate as a supplement to prevent neural tube defects

Inventors: Dean R. Appling (Austin, TX); Jessica E. Momb (Austin, TX)
Assignee: Board of Regents, The University of Texas System
A61K31/19A23K20/174A23K20/24A23L7/117A23L33/15A23L33/16A61K9/00A61K31/14A61K31/519A61K31/714A61K33/26A61K45/06C12N15/86C12N2760/00043C12N2760/00051C12N2770/00043C12N2770/00051
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,895,328
App. No.
14/912,044
Granted
Feb 20, 2018
Kind
B2
Abstract

Compositions and method for treating a folate-resistant disease in a subject are disclosed. The methods involve administering to the subject an effective amount of a composition containing a formate. For example, the method can be used to reducing the risk of neural tube defects during pregnancy. The method can also be used to treat other conditions normally treatable by folate supplementation.

Claims (8)

1. A method for reducing the risk of neural tube defects during pregnancy in a subject, comprising administering to a pregnant subject an effective amount of a composition comprising a formate.

2. The method of claim 1 , wherein the formate comprises a salt or ester of formic acid.

3. The method of claim 2 , wherein the formate comprises calcium formate, sodium formate, ammonium formate, potassium formate, magnesium formate, or a combination thereof.

4. The method of claim 3 , wherein the formate comprises calcium formate.

5. The method of claim 1 , wherein the composition further comprises vitamin B12.

6. The method of claim 1 , wherein the composition further comprises iron.

7. The method of claim 1 , wherein the composition further comprises choline.

8. The method of claim 1 , wherein the composition comprises about 0.5 mg to about 10,000 mg of the formate.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2018
From: APPLING, DEAN R.; MOMB, JESSICA E.
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 044570/0008 →
CONFIRMATORY LICENSE Recorded Jul 11, 2016
From: UNIVERSITY OF TEXAS, AUSTIN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039299/0525 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2016
From: APPLING, DEAN R.; MOMB, JESSICA E.
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 037768/0341 →
Continuity (2)
Provisional Application 61866331 · Aug 15, 2013
Related Publication 20160193164A1 · Jul 7, 2016